Memorial Sloan Kettering Cancer Center
New York, 10065, United States
NCT Number: NCT00639301
The purpose of this study is to find out about the quality of life and health in a group of adults who had retinoblastoma when they were children. By quality of life, we mean how you are feeling about being satisfied with things in your life, including your physical health, your emotional health, and your ability to carry out daily activities. We hope that this information will help us provide better care to future children with retinoblastoma and better follow-up care for survivors of retinoblastoma.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
New York, 10065, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The survey will be administered by mail or telephone interview, based upon the participant preference. The survey has been adapted from the 2008 questionnaire being administered through the CCSS (11); it has been supplemented with questions addressing areas of interest specific to the retinoblastoma survivor population (eg, validated instruments that assess visual impairment).
Time frame: conclusion of study
Time frame: conclusion of study
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03655223
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT01783535
Eye Diseases, Eye Diseases, Hereditary
Memphis, Tennessee, United States
View Trial DetailsNCT04483778
Carcinoma, Clear Cell Sarcoma
Seattle, Washington, United States
View Trial DetailsNCT02870907
Eye Diseases, Eye Diseases, Hereditary
Saint-Denis, La Réunion, France
View Trial Details